Ahl Scott, Guenther Mitchell, Zhao Shi, James Roland, Marks Jacqueline, Szabo Aniko, Kidambi Srividya
Department of Medicine (S.A., M.G., R.J., J.M., S.K.), and Institute of Health and Society (S.Z., A.S.), Medical College of Wisconsin, Milwaukee, Wisconsin 53226.
J Clin Endocrinol Metab. 2015 Nov;100(11):4172-80. doi: 10.1210/jc.2015-2765. Epub 2015 Sep 24.
Adiponectin levels (ADPN) are lower in individuals with central obesity and cardiometabolic diseases. Conversely, studies have shown paradoxical hyperadiponectinemia (HA) in metabolically healthy obese (MHO) individuals of non-European descent. Moreover, individuals with higher sc to visceral adipose tissue (ie, higher peripheral adiposity) distribution have higher ADPNs. However, it is not known whether metabolically healthy individuals have predominantly peripheral adiposity along with higher ADPNs.
This study aimed to evaluate the association of ADPN and adiposity distribution with metabolic health in white individuals.
This was a cross-sectional study of members of "Take Off Pounds Sensibly" weight loss club and their relatives.
We recruited 2486 (72% women, 61% obese) individuals. They were defined as metabolically healthy by absence of hypertension, diabetes, and dyslipidemia; and they were further classified into metabolically healthy nonobese (MHNO), metabolically unhealthy nonobese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Waist-to-hip ratios (WHRs) were used as markers of adiposity distribution. Insulin resistance was measured using homeostasis model assessment.
Among the four groups, MHNO had the lowest WHRs (higher peripheral adiposity) and highest ADPN, and MUO had highest WHRs (higher central adiposity) and lowest ADPN (P < .001). Among both nonobese and obese, metabolically healthy individuals had higher ADPN than metabolically unhealthy individuals (P < .05) after adjustment for age, sex, and body mass index. MHNO also had lower WHRs compared with MUNO (P < .01). Although WHRs were lower among MHO compared with MUO, the difference was not significant. In addition, nonobese and obese individuals with HA (defined using sex-specific cutoffs) had lower homeostasis model assessment and dyslipidemia compared with individuals without HA.
Higher ADPN and lower WHRs (higher peripheral adiposity) are associated with better metabolic health in both nonobese and obese white individuals. These results suggest that ADPN and peripheral adiposity play a key role in determining the metabolic health independent of body mass index.
中心性肥胖和心血管代谢疾病患者的脂联素水平(ADPN)较低。相反,研究表明非欧洲血统的代谢健康肥胖(MHO)个体存在矛盾的高脂联素血症(HA)。此外,皮下脂肪与内脏脂肪组织比例较高(即外周肥胖程度较高)的个体ADPN水平也较高。然而,尚不清楚代谢健康的个体是否主要具有外周肥胖以及较高的ADPN水平。
本研究旨在评估白种人中ADPN和肥胖分布与代谢健康之间的关联。
这是一项对“明智减重”减肥俱乐部成员及其亲属的横断面研究。
我们招募了2486名个体(72%为女性,61%为肥胖者)。他们被定义为代谢健康,即无高血压、糖尿病和血脂异常;并进一步分为代谢健康非肥胖(MHNO)、代谢不健康非肥胖(MUNO)、代谢健康肥胖(MHO)和代谢不健康肥胖(MUO)。腰臀比(WHR)用作肥胖分布的指标。使用稳态模型评估来测量胰岛素抵抗。
在这四组中,MHNO的WHR最低(外周肥胖程度较高)且ADPN最高,而MUO的WHR最高(中心肥胖程度较高)且ADPN最低(P <.001)。在非肥胖和肥胖个体中,调整年龄、性别和体重指数后,代谢健康的个体比代谢不健康的个体具有更高的ADPN(P <.05)。与MUNO相比,MHNO的WHR也更低(P <.01)。尽管MHO的WHR低于MUO,但差异不显著。此外,与无HA的个体相比,有HA(使用性别特异性临界值定义)的非肥胖和肥胖个体的稳态模型评估和血脂异常情况更低。
较高的ADPN和较低的WHR(外周肥胖程度较高)与非肥胖和肥胖白种人的更好代谢健康相关。这些结果表明,ADPN和外周肥胖在决定代谢健康方面起着关键作用,独立于体重指数。